SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Psychiatric risks for worsened mental health after psychedelic use
16 references·0 citing·40 second hop
Psychiatric risks for worsened mental health after psychedelic use (2024)Psychiatric risks for worsened mental hea…Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression (2022)Single-Dose Psilocybin for a …Trial of Psilocybin versus Escitalopram for Depression (2021)Trial of Psilocybin versus Es…REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics (2019)REBUS and the Anarchic Brain:…The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future (2017)The Therapeutic Potential of …Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study (2016)Psilocybin with psychological…Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial (2016)Psilocybin produces substanti…Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study (2015)Psilocybin-assisted treatment…Diagnostic and Statistical Manual of Mental Disorders (2013)Diagnostic and Statistical Ma…Internal construct validity of the Warwick-Edinburgh Mental Well-being Scale (WEMWBS): a Rasch analysis using data from the Scottish Health Education Population Survey (2009)Internal construct validity o…The Revised NEO Personality Inventory (NEO-PI-R) (2008)The Revised NEO Personality I…Human hallucinogen research: guidelines for safety (2008)Human hallucinogen research: …A meta-analytic review of the relationships between the five-factor model and DSM-IV-TR personality disorders: A facet level analysis (2008)A meta-analytic review of the…The Warwick-Edinburgh Mental Well-being Scale (WEMWBS): development and UK validation (2007)The Warwick-Edinburgh Mental …Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder (2006)Safety, Tolerability, and Eff…A very brief measure of the Big-Five personality domains (2003)A very brief measure of the B…Cognitive-Behavioral Treatment of Borderline Personality Disorder (1994)Cognitive-Behavioral Treatmen…Hallucinogens (2004)Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance (2006)Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer (2010)Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects (2011)DSM‐IV‐TR: Diagnostic and Statistical Manual of Mental Disorders (2013)Psilocybin with psychological support for treatment-resistant depression: six-month follow-up (2017)The Satisfaction With Life Scale (1985)Development and validation of brief measures of positive and negative affect: The PANAS scales. (1988)Cutoff criteria for fit indexes in covariance structure analysis: Conventional criteria versus new alternatives (1999)Flourishing Across Europe: Application of a New Conceptual Framework for Defining Well-Being (2011)A Large-Scale Test of the Goldilocks Hypothesis (2017)Well-being is more than happiness and life satisfaction: a multidimensional analysis of 21 countries (2020)Coefficient Alpha and the Internal Structure of Tests (1951)Probabilistic Models for Some Intelligence and Attainment Tests (1961)A Rasch Model for Partial Credit Scoring (1982)The PERMA-Profiler: A brief multidimensional measure of flourishing (2016)Construct validity in psychological tests. (1955)Society and the Adolescent Self-Image (1965)The Big Five Trait taxonomy: History, measurement, and theoretical perspectives. (1999)Measuring personality in one minute or less: A 10-item short version of the Big Five Inventory in English and German (2006)The Mini-IPIP Scales: Tiny-yet-effective measures of the Big Five Factors of Personality. (2006)The dirty dozen: A concise measure of the dark triad. (2010)Manual for the State-Trait Anxiety Inventory (1970)The Hospital Anxiety and Depression Scale (1983)Optimism, coping, and health: Assessment and implications of generalized outcome expectancies. (1985)Psychedelics (2016)Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial (2016)Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder (2022)Single-Dose Psilocybin Treatment for Major Depressive Disorder (2023)The Five Factor Model and impulsivity: using a structural model of personality to understand impulsivity (2001)Mindfulness-Based Interventions in Context: Past, Present, and Future (2003)Mindfulness: Theoretical Foundations and Evidence for its Salutary Effects (2007)Psychedelics Promote Structural and Functional Neural Plasticity (2018)Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder (2020)Identifying careless responses in survey data. (2012)Personality, Gender, and Age in the Language of Social Media: The Open-Vocabulary Approach (2013)Methods for the detection of carelessly invalid responses in survey data (2015)Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation (1988)The structure of negative emotional states: Comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories (1995)The Posttraumatic Stress Disorder Checklist for DSM‐5 (PCL‐5): Development and Initial Psychometric Evaluation (2015)
this work references cited by second hop

References

  • 2013Diagnostic and Statistical Manual of Mental Disorders116,254 cited
  • 2003A very brief measure of the Big-Five personality domains8,303 cited
  • 1994Cognitive-Behavioral Treatment of Borderline Personality Disorder6,278 cited
  • 2007The Warwick-Edinburgh Mental Well-being Scale (WEMWBS): development and UK validation5,027 cited
  • 2016Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial2,196 cited
  • 2008The Revised NEO Personality Inventory (NEO-PI-R)1,563 cited
  • 2016Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study1,533 cited
  • 2021Trial of Psilocybin versus Escitalopram for Depression1,386 cited
  • 2009Internal construct validity of the Warwick-Edinburgh Mental Well-being Scale (WEMWBS): a Rasch analysis using data from the Scottish Health Education Population Survey1,247 cited
  • 2008Human hallucinogen research: guidelines for safety1,201 cited
  • 2019REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics1,175 cited
  • 2022Single-Dose Psilocybin for a Treatment-Resistant Episode of Major Depression1,164 cited
  • 2015Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study1,150 cited
  • 2008A meta-analytic review of the relationships between the five-factor model and DSM-IV-TR personality disorders: A facet level analysis

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

1,017 cited
  • 2006Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder789 cited
  • 2017The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future700 cited
  • Cited by

    No citing works inside the corpus for this window.